Doug Lockyer

Firstly, Doug identified exactly where in the Biotechnology process ProteoMetrics fit in and in exactly what manner and to what extent the software added value, and to whom.

Then he identified the value proposition in terms of achievable market share, not only in terms of software sales supported by integration services, but also as an OEM / VAR proposition for Biotech equipment manufacturers.

Protein identification requires calibrated and highly expensive mass spectrometry equipment, sophisticated and precise methodologies and robust, scaleable database software. To this end, partnering with equipment manufacturers and retaining methodology experts as field consultants was resolved as the most powerful strategy.